RP-3 by Replimune for Melanoma: Likelihood of Approval

RP-3 is under clinical development by Replimune and currently in Phase I for Melanoma.

Colorado weather: Severe thunderstorm, 2-inch hail forecast – The Cannabist

A severe thunderstorm could bring 2-inch hail, wind gusts up to 70 mph and frequent lightning to Colorado’s Eastern Plains and communities east of the

August 19, 2024

The FDA Issues Guidance on Designing Psychedelic Clinical Trials | Psychedelic Spotlight

On June 23rd of this year, the U.S. Food and Drug Administration published a new draft guidance intended to advise researchers on study design when

June 27, 2023

Moderna’s Covid and flu combo vaccine succeeds in Phase 3 study

Moderna’s Covid-19 and influenza combination vaccine was comparable to shots separately marketed for the two infections in a Phase 3 trial, the company announced Monday

June 11, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.